Flohmarkt auf dem Vertex Parkplatz in Kirchbichl. KIRCHBICHL. Viele verschiedene Flohmarkt-Sachen können wöchentlich bei jedem Wetter bis in den Herbst durchgehend auf dem Vertex Parkplatz in ...

Vertex (VERX) announced the expansion of its Chief Strategy Office with the addition of Christopher Hall and Kathya Capote Peimbert. Their ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

In der 16. Runde der Tirol Liga begann das Duell zwischen dem SV Kirchbichl und dem SV Brixen programmgemäß. Kirchbichl führte nach einer Viertelstunde bereits mit 2:0, doch dann wurde es für den ...

In einem mitreißenden Spiel der Tirol Liga setzte sich der SV Kirchbichl mit 4:2 beim FC Stubai durch. Die Begegnung in der 17. Runde war von Anfang an von intensiven Zweikämpfen und spannenden ...

Christoph Mayr, Obmann Lukas Haberl, Hannes Schrattenthaler, Michael Kwasnitzka, Johann Laiminger, Georg Kwasnitzka, Bianca Egger und Bgm Herbert Rieder (v.l.) Foto: BMK Kirchbichl hochgeladen von ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...